ZBIO
Zenas BioPharma·NASDAQ
--
--(--)
--
--(--)
6.28 / 10
Outperform
Analyst sentiment is bullish: three Strong Buy and one Neutral rating, weighted rating 5.01, and a 6.28 sentiment score. Fund flow scores 7.55, with positive small‑, medium‑ and large‑size inflows, though overall trend is negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
75%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Judah FrommerNeutral
Date2026-03-17
InstitutionMorgan Stanley
Times predicted3
Historical Win Rate33.3%
Matthew CaufieldStrong Buy
Yatin SunejaStrong Buy
Yigal NochomovitzStrong Buy
What is the market sentiment for ZBIO?
- ZBIO holds a Bullish analyst rating, with 75% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.28/10 (Outperform).
